Enoxaparin sodium is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. Other uses include inside kidney dialysis machines.
Common side effects include bleeding, fever, and swelling of the legs. Bleeding may be serious especially in those who are undergoing a spinal tap. Use during pregnancy appears to be safe for the baby. Enoxaparin is in the low molecular weight heparin family of medications.

Market Analysis and Insights: Global Enoxaparin Sodium Market
The global Enoxaparin Sodium market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Enoxaparin Sodium Scope and Market Size
The global Enoxaparin Sodium market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Enoxaparin Sodium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
30 mg/0.3mL
60 mg/0.6mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL

Segment by Application
Hospital
Drugs Store

The Enoxaparin Sodium market is analysed and market size information is provided by regions (countries). Segment by Application, the Enoxaparin Sodium market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Sanodz
Themis Medicare Limited
Shenzhen Techdow Pharmaceutical
Sanofi
Jianyou
Amphastar Pharmaceuticals, Inc.
Actavis Pharma Company
Winthrop U.S.
Cardinal Health
NorthStar Rx
Teva Parenteral Medicines